Lung cancers, and notably Lung Adenocarcinomas (LUAD) are the leading cause of cancer death worldwide. Their high rate of recurrence despite early, requires new prognostic markers and new therapeutic targets. The combined study of local cohort (CHU of Nice) and large scale (TCGA) transcriptomes of LUAD allowed the identification of a shortlist...
-
November 13, 2020 (v1)PublicationUploaded on: December 4, 2022
-
November 24, 2023 (v1)Publication
Abstract Single-cell CRISPR-based transcriptome screens are potent genetic tools for concomitantly assessing the expression profiles of cells targeted by a set of guides RNA (gRNA), and inferring target gene functions from the observed perturbations. However, due to various limitations, this approach lacks sensitivity in detecting weak...
Uploaded on: November 27, 2023 -
October 19, 2020 (v1)Journal article
Mammary carcinoma, including triple-negative breast carcinomas (TNBC) are tumor-types for which human and canine pathologies are closely related at the molecular level. The efficacy of an oncolytic vaccinia virus (VV) was compared in low-passage primary carcinoma cells from TNBC versus non-TNBC. Non-TNBC cells were 28 fold more sensitive to VV...
Uploaded on: December 4, 2022 -
November 24, 2023 (v1)Publication
ABSTRACT Introduction and main objectives Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and irreversible interstitial lung disease (ILD), that increases dramatically in incidence and prevalence with age. While successful alveolar regeneration after injury depends on pulmonary capillary endothelial cells (PCEC) reprogramming, the...
Uploaded on: November 27, 2023